N. Verbeke

535 total citations
19 papers, 467 citations indexed

About

N. Verbeke is a scholar working on Ophthalmology, Pharmacology and Molecular Biology. According to data from OpenAlex, N. Verbeke has authored 19 papers receiving a total of 467 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Ophthalmology, 4 papers in Pharmacology and 3 papers in Molecular Biology. Recurrent topics in N. Verbeke's work include Drug-Induced Ocular Toxicity (4 papers), Innovative Microfluidic and Catalytic Techniques Innovation (3 papers) and Plant-based Medicinal Research (3 papers). N. Verbeke is often cited by papers focused on Drug-Induced Ocular Toxicity (4 papers), Innovative Microfluidic and Catalytic Techniques Innovation (3 papers) and Plant-based Medicinal Research (3 papers). N. Verbeke collaborates with scholars based in Belgium and United States. N. Verbeke's co-authors include A. D’Hulst, Patrick Augustijns, Piet Geusens, Anne Jeanjean, Renaat Kinget, Michel Lesne, H.W. Jongsma, Peter de Witte, Michael Ikechukwu Ugwoke and J. Roba and has published in prestigious journals such as European Heart Journal, Journal of Chromatography A and European Journal of Clinical Pharmacology.

In The Last Decade

N. Verbeke

18 papers receiving 445 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
N. Verbeke Belgium 9 180 179 63 57 53 19 467
Massimo Breda Italy 16 73 0.4× 130 0.7× 249 4.0× 72 1.3× 6 0.1× 34 678
E. Pianezzola Italy 14 21 0.1× 94 0.5× 118 1.9× 88 1.5× 42 0.8× 32 567
Narayanan Surendran United States 12 24 0.1× 53 0.3× 146 2.3× 24 0.4× 9 0.2× 22 462
Takashi Tomita Japan 13 16 0.1× 76 0.4× 244 3.9× 35 0.6× 43 0.8× 42 655
Richard Vistelle France 12 27 0.1× 30 0.2× 71 1.1× 76 1.3× 15 0.3× 49 424
Pokar M. Kabra United States 15 60 0.3× 144 0.8× 336 5.3× 143 2.5× 16 0.3× 23 702
Wen Pan China 14 146 0.8× 30 0.2× 208 3.3× 63 1.1× 11 0.2× 38 627
Lars‐Inge Olsson Sweden 15 13 0.1× 43 0.2× 81 1.3× 38 0.7× 22 0.4× 27 513
S.L. Malcolm United Kingdom 11 18 0.1× 27 0.2× 169 2.7× 21 0.4× 42 0.8× 13 509
Jennifer L. H. Johnson United States 10 66 0.4× 68 0.4× 54 0.9× 19 0.3× 36 0.7× 16 412

Countries citing papers authored by N. Verbeke

Since Specialization
Citations

This map shows the geographic impact of N. Verbeke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. Verbeke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. Verbeke more than expected).

Fields of papers citing papers by N. Verbeke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N. Verbeke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. Verbeke. The network helps show where N. Verbeke may publish in the future.

Co-authorship network of co-authors of N. Verbeke

This figure shows the co-authorship network connecting the top 25 collaborators of N. Verbeke. A scholar is included among the top collaborators of N. Verbeke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N. Verbeke. N. Verbeke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Ugwoke, Michael Ikechukwu, Remigius U. Agu, Renaat Kinget, & N. Verbeke. (2003). Intravenous versus subcutaneous injections of apomorphine in rabbits: a pharmacokinetic paradox.. PubMed. 142(8). 315–8. 2 indexed citations
2.
Agu, Remigius U., Mark Jorissen, Tom Willems, et al.. (2002). Derivatized and fibrillar collagen films as scaffold for nasal epithelial cells to study nasal drug absorption in vitro. Lirias (KU Leuven). 12(1). 81–87. 5 indexed citations
3.
D’Hulst, A., et al.. (1996). Determination of Artesunate by Capillary Electrophoresis with Low UV Detection and Possible Applications to Analogues. Journal of Chromatographic Science. 34(6). 276–281. 14 indexed citations
4.
D’Hulst, A. & N. Verbeke. (1996). Chiral analysis of basic drugs by oligosaccharide-mediated capillary electrophoresis. Journal of Chromatography A. 735(1-2). 283–293. 46 indexed citations
5.
Verbeke, N., et al.. (1995). Free radical scavenging properties of apomorphine enantiomers and dopamine: Possible implication in their mechanism of action in parkinsonism. Journal of Neural Transmission - Parkinsons Disease and Dementia Section. 10(2-3). 115–127. 40 indexed citations
6.
Jeanjean, Anne, et al.. (1995). Apomorphine pharmacokinetics in Parkinsonism after intranasal and subcutaneous application. European Journal of Drug Metabolism and Pharmacokinetics. 20(1). 27–33. 48 indexed citations
7.
Augustijns, Patrick, et al.. (1994). Stability of apomorphine in plasma and its determination by high-performance liquid chromatography with electrochemical detection. Journal of Chromatography B Biomedical Sciences and Applications. 658(2). 311–317. 36 indexed citations
8.
Hérin, Michel, et al.. (1994). Comparative metabolism of SC-42867 and SC-51089, two PGE2antagonists, in rat and human hepatocyte cultures. Xenobiotica. 24(1). 25–36. 12 indexed citations
9.
Croes, Kathleen, Patrick Augustijns, Marc Sabbé, K. Desmet, & N. Verbeke. (1993). Diminished sedation during diazepam treatment for chloroquine intoxication. Pharmacy World & Science. 15(2). 83–85. 4 indexed citations
10.
Augustijns, Patrick, Piet Geusens, & N. Verbeke. (1993). Chloroquine pharmacokinetic data during chronic daily treatment. European Journal of Clinical Pharmacology. 44(4). 409–410. 2 indexed citations
11.
Augustijns, Patrick, Piet Geusens, & N. Verbeke. (1992). Chloroquine levels in blood during chronic treatment of patients with rheumatoid arthritis. European Journal of Clinical Pharmacology. 42(4). 429–433. 84 indexed citations
12.
D’Hulst, A. & N. Verbeke. (1992). Chiral separation by capillary electrophoresis with oligosaccharides. Journal of Chromatography A. 608(1-2). 275–287. 136 indexed citations
13.
Augustijns, Patrick & N. Verbeke. (1992). A Microassay Method for the Determination of Theophylline in Biological Samples Using HPLC with Electrochemical Detection. Journal of Liquid Chromatography. 15(8). 1303–1313. 6 indexed citations
14.
Augustijns, Patrick, H.W. Jongsma, & N. Verbeke. (1991). Transplacental Distribution of Chloroquine in Sheep. Developmental Pharmacology and Therapeutics. 17(3-4). 191–199. 7 indexed citations
15.
Augustijns, Patrick & N. Verbeke. (1990). HPLC Method for the Determination of Chloroquine and its Main Metabolite in Biological Samples. Journal of Liquid Chromatography. 13(6). 1203–1213. 17 indexed citations
16.
Stroobandt, Roland, et al.. (1987). Effects of intravenous sotalol, aprindine and the combination of sotalol and aprindine on chronic high frequency ventricular arrhythmias in man. European Heart Journal. 8(4). 372–377. 3 indexed citations
17.
Thunus, L, et al.. (1980). [Synthesis and pharmacological property of some 4-(4-phenylpiperazin-1-yl)pyridine-3-sulfonamides (author's transl)].. PubMed. 38(4). 353–8.
18.
Verbeke, N., et al.. (1979). The binding of gitoxin to human plasma proteins. European Journal of Clinical Pharmacology. 16(5). 341–344. 4 indexed citations
19.
Godfraind, Théophile, X Sturbois, & N. Verbeke. (1973). Ultrastructure du muscle longitudinal de l'iléon de cobaye et de ses microsomes.. Archives of Physiology and Biochemistry. 81(4). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026